182 related articles for article (PubMed ID: 25444840)
1. Development, in vitro and in vivo characterization of zoledronic acid functionalized hydroxyapatite nanoparticle based formulation for treatment of osteoporosis in animal model.
Khajuria DK; Razdan R; Mahapatra DR
Eur J Pharm Sci; 2015 Jan; 66():173-83. PubMed ID: 25444840
[TBL] [Abstract][Full Text] [Related]
2. Zoledronic acid in combination with alfacalcidol has additive effects on trabecular microarchitecture and mechanical properties in osteopenic ovariectomized rats.
Khajuria DK; Razdan R; Mahapatra DR
J Orthop Sci; 2014 Jul; 19(4):646-56. PubMed ID: 24668309
[TBL] [Abstract][Full Text] [Related]
3. Novel therapeutic intervention for osteoporosis prepared with strontium hydroxyapatite and zoledronic acid: In vitro and pharmacodynamic evaluation.
Khajuria DK; Vasireddi R; Trebbin M; Karasik D; Razdan R
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():698-708. PubMed ID: 27987763
[TBL] [Abstract][Full Text] [Related]
4. Additive effects of zoledronic acid and propranolol on bone density and biochemical markers of bone turnover in osteopenic ovariectomized rats.
Khajuria DK; Razdan R; Mahapatra DR
Rev Bras Reumatol; 2015; 55(2):103-12. PubMed ID: 25582996
[TBL] [Abstract][Full Text] [Related]
5. Risedronate/zinc-hydroxyapatite based nanomedicine for osteoporosis.
Khajuria DK; Disha C; Vasireddi R; Razdan R; Mahapatra DR
Mater Sci Eng C Mater Biol Appl; 2016 Jun; 63():78-87. PubMed ID: 27040198
[TBL] [Abstract][Full Text] [Related]
6. Oral delivery of zoledronic acid by non-covalent conjugation with lysine-deoxycholic acid: In vitro characterization and in vivo anti-osteoporotic efficacy in ovariectomized rats.
Jeon OC; Seo DH; Kim HS; Byun Y; Park JW
Eur J Pharm Sci; 2016 Jan; 82():1-10. PubMed ID: 26542347
[TBL] [Abstract][Full Text] [Related]
7. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats.
Hornby SB; Evans GP; Hornby SL; Pataki A; Glatt M; Green JR
Calcif Tissue Int; 2003 Apr; 72(4):519-27. PubMed ID: 12574877
[TBL] [Abstract][Full Text] [Related]
8. Osteoprotective effect of propranolol in ovariectomized rats: a comparison with zoledronic acid and alfacalcidol.
Khajuria DK; Razdan R; Mahapatra DR; Bhat MR
J Orthop Sci; 2013 Sep; 18(5):832-42. PubMed ID: 23835529
[TBL] [Abstract][Full Text] [Related]
9. Effect of combined treatment with zoledronic acid and propranolol on mechanical strength in an rat model of disuse osteoporosis.
Khajuria DK; Razdan R; Mahapatra DR
Rev Bras Reumatol; 2015; 55(6):501-11. PubMed ID: 25480532
[TBL] [Abstract][Full Text] [Related]
10. Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate.
McClung M; Recker R; Miller P; Fiske D; Minkoff J; Kriegman A; Zhou W; Adera M; Davis J
Bone; 2007 Jul; 41(1):122-8. PubMed ID: 17468062
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: a randomized, multicenter, double-blind, active-controlled study.
Orwoll ES; Miller PD; Adachi JD; Brown J; Adler RA; Kendler D; Bucci-Rechtweg C; Readie A; Mesenbrink P; Weinstein RS
J Bone Miner Res; 2010 Oct; 25(10):2239-50. PubMed ID: 20499357
[TBL] [Abstract][Full Text] [Related]
12. Improvement in bone properties by using risedronate adsorbed hydroxyapatite novel nanoparticle based formulation in a rat model of osteoporosis.
Sahana H; Khajuria DK; Razdan R; Mahapatra DR; Bhat MR; Suresh S; Rao RR; Mariappan L
J Biomed Nanotechnol; 2013 Feb; 9(2):193-201. PubMed ID: 23627045
[TBL] [Abstract][Full Text] [Related]
13. Loss of vertebral bone and mechanical strength in estrogen-deficient rats is prevented by long-term administration of zoledronic acid.
Glatt M; Pataki A; Evans GP; Hornby SB; Green JR
Osteoporos Int; 2004 Sep; 15(9):707-15. PubMed ID: 15024556
[TBL] [Abstract][Full Text] [Related]
14. Effect of systemic administered zoledronic acid on osseointegration of a titanium implant in ovariectomized rats.
Dikicier E; Karaçaylı Ü; Dikicier S; Günaydın Y
J Craniomaxillofac Surg; 2014 Oct; 42(7):1106-11. PubMed ID: 24530079
[TBL] [Abstract][Full Text] [Related]
15. Influence of early and late zoledronic acid administration on vertebral structure and strength in ovariectomized rats.
Brouwers JE; van Rietbergen B; Bouxsein ML
Calcif Tissue Int; 2008 Sep; 83(3):186-91. PubMed ID: 18712432
[TBL] [Abstract][Full Text] [Related]
16. [Additive effect of zoledronic acid and alfacalcidol in the treatment of disuse osteoporosis in rats].
Khajuria DK; Disha C; Razdan R; Mahapatra DR
Rev Bras Reumatol; 2015; 55(3):240-50. PubMed ID: 25440697
[TBL] [Abstract][Full Text] [Related]
17. Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat.
Gasser JA; Ingold P; Venturiere A; Shen V; Green JR
J Bone Miner Res; 2008 Apr; 23(4):544-51. PubMed ID: 18072878
[TBL] [Abstract][Full Text] [Related]
18. Diminished Progression of Periapical Lesions with Zoledronic Acid in Ovariectomized Rats.
Wayama MT; Yoshimura H; Ohba S; Yoshida H; Matsuda S; Kobayashi J; Kobayashi M; Gomes Filho JE; Sano K
J Endod; 2015 Dec; 41(12):2002-7. PubMed ID: 26490005
[TBL] [Abstract][Full Text] [Related]
19. Effect on bone turnover markers of once-yearly intravenous infusion of zoledronic acid versus daily oral risedronate in patients treated with glucocorticoids.
Devogelaer JP; Sambrook P; Reid DM; Goemaere S; Ish-Shalom S; Collette J; Su G; Bucci-Rechtweg C; Papanastasiou P; Reginster JY
Rheumatology (Oxford); 2013 Jun; 52(6):1058-69. PubMed ID: 23365149
[TBL] [Abstract][Full Text] [Related]
20. The combination therapy with zoledronic Acid and propranolol improves the trabecular microarchitecture and mechanical property in an rat model of postmenopausal osteoporosis.
Khajuria DK; Razdan R; Mahapatra DR
J Osteoporos; 2014; 2014():586431. PubMed ID: 24800099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
